Are you Dr. Huber?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 21 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8th Avenue C Street E8
Salt Lake City, UT 84143Phone+1 801-408-1819
Summary
- Dr. Bryan Huber, MD is an oncologist in Salt Lake City, Utah. He is currently licensed to practice medicine in Utah, Colorado, and Idaho. He is affiliated with LDS Hospital, Intermountain Medical Center, and Alta View Hospital.
Education & Training
- University of TennesseeFellowship, Hematology and Medical Oncology, 2016 - 2019
- University of Tennessee (Nashville)Residency, Internal Medicine, 2013 - 2016
- University of Arizona College of MedicineClass of 2013
Certifications & Licensure
- UT State Medical License 2019 - 2026
- CO State Medical License 2020 - 2025
- ID State Medical License 2020 - 2025
- MT State Medical License 2019 - 2025
- NV State Medical License 2020 - 2025
- TN State Medical License 2018 - 2021
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 8 citationsReal-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma.Matko Kalac, Salvia Jain, Constantine S Tam, Zhengrui Xiao, Francesca Montanari
Blood Advances. 2023-07-25 - 1 citationsGenome-wide uniparental disomy as a mechanism of immune escape in acquired aplastic anaemia.Srinivas K Tantravahi, Bryan D Huber, Jennie Vagher, Luke Maese, Anthony D Pomicter
British Journal of Haematology. 2022-09-01 - 9 citationsSuccessful administration of chimeric antigen receptor (CAR) T-cell therapy in patients requiring hemodialysis.Bradley D Hunter, Daanish Hoda, Andy Nguyen, Launce Gouw, Bryan Huber
Experimental Hematology & Oncology. 2022-02-28